Updates in Medicine articles by specialty
Endocrinology and Diabetology
5 articles · Newest first
2026 ADA/EASD Type 2 Diabetes Management Update: From Glucose Control to Early Organ Protection
A practical guide to the 2026 consensus: consider organ-protective treatment early, then individualise care around cardiovascular and kidney risk, weight and glycaemic goals.
2026 Pharmacological Management of MASH: Selecting, Starting and Monitoring Therapy
EASL–EASD–EASO guidance in practice: selecting eligible adults with non-cirrhotic F2–F3 MASH, choosing between resmetirom and semaglutide, and monitoring response and safety.
Retatrutide: First-in-Class Triple Agonism with Benefits Beyond Weight Reduction
The phase 3 TRIUMPH-1 trial evaluated once-weekly GIP–GLP-1–glucagon triple-receptor agonism in adults with obesity without diabetes.
Short oral corticosteroid courses in type 2 diabetes: what the 30-day safety signal means
A nationwide study links brief oral corticosteroid treatment with gastrointestinal bleeding, pneumonia and heart failure soon after initiation.
Met-HeFT 2026: Metformin Failed to Reduce Cardiovascular Events in HFrEF
The randomised trial tested whether metformin provides cardiovascular protection beyond glucose lowering in HFrEF.